ARCHETYPE Sequencing assay (openEHR-EHR-CLUSTER.sequencing_assay.v0)

ARCHETYPE IDopenEHR-EHR-CLUSTER.sequencing_assay.v0
ConceptSequencing assay
DescriptionTo record details of the sequencing analysis including a list of all tested genes if panel sequencing was performed.
UseOne or more instances of this archetype may be nested within the 'Testing details' SLOT in the OBSERVATION.laboratory_test_result.
MisuseUsed only to document the analysis protocol but not to document the results of the sequence analysis. The results are documented with the archetype 'genetic variant'.
PurposeTo record details of the performed sequencing analysis including a list of all tested genes if panel sequencing was performed.
References
Copyright© HiGHmed, openEHR Foundation, openEHR Foundation
AuthorsAuthor name: Aurelie Tomczak
Organisation: Institute of Pathology, University Hospital Heidelberg
Email: au.tomczak@yahoo.com
Date originally authored: 2019-06-24
Other Details LanguageAuthor name: Aurelie Tomczak
Organisation: Institute of Pathology, University Hospital Heidelberg
Email: au.tomczak@yahoo.com
Date originally authored: 2019-06-24
Other Details (Language Independent)
  • Licence: This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/.
  • Custodian Organisation: Ocean Informatics
  • Original Namespace: com.oceaninformatics
  • Original Publisher: Ocean Informatics
  • Custodian Namespace: com.oceaninformatics
  • MD5-CAM-1.0.1: 6DB57FE3BECC443D3BCE4ED5AE054B5E
  • Build Uid: d63f49cd-fed8-4416-bc08-a580cc43cc31
  • Revision: 0.0.1-alpha
KeywordsSequencing, Genomics, Panel, Assay, Pathology, Sequencing analysis, Panel sequencing, Gene, Specimen
Lifecyclein_development
UID20311eb5-8d7b-407f-8fcc-6b2a15833438
Language useden
Citeable Identifier1013.1.2348
Revision Number0.0.1-alpha
items
Sequencing technologySequencing technology: Name of the technology used for sequencing analysis.
Choice of:
  •  Coded Text
    • NGS (hybrid-capture) [*]
    • NGS (amplicon) [*]
    • Genome sequencing [*]
    • Array-CGH [*]
    • MLPA [*]
    • Sanger sequencing [*]
    • Fragment analysis [*]
    • Methylation assay [*]
    • Miscellaneous [*]
  •  Text
Sequencing or analysis deviceSequencing or analysis device: Used to specify devices and tools used for the sequencing analysis or result annotation.
e.g. Sequencing device, alignment method, variant caller
Include:
openEHR-EHR-CLUSTER.device.v1 and specialisations
Kit nameKit name: Name of the kit used for the experiment.
Choice of:
  •  Text
  •  Coded Text
    • Oncomine Comprehensive Panel V3 [*]
Nucleic acidNucleic acid: Type of nucleic acid used for sequencing, e.g. DNA, RNA oder cf-DNA.
Choice of:
  •  Text
  •  Coded Text
    • DNA [*]
    • RNA [*]
    • cf-DNA [*]
Tumor cell percentageTumor cell percentage: To record the tumor cell content in percent.
min: >=0; max: <=100

Tested GenesTested Genes: List of all tested genes, if panel sequencing was performed.
Gen symbolGen symbol: The official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
Gen nameGen name: The full gene name approved by the HGNC that convey the character or function of the gene.
Gene reference sequenceGene reference sequence: Structured details on the reference sequence of the gene.
Include:
openEHR-EHR-CLUSTER.reference_sequence.v1 and specialisations
Tested RegionTested Region: List of all tested regions, if panel sequencing was performed.
Chromosomal locationChromosomal location: Chromosomal location of tested region.
Choice of:
  •  Text
  •  Coded Text
StartStart: Start position of the tested region.
EndEnd: End position of the tested region.
Reference sequence of regionReference sequence of region: Structured details on the reference sequence of the region.
Include:
openEHR-EHR-CLUSTER.reference_sequence.v1 and specialisations
ExtensionsExtensions: Additional details to be captured.
Include:
All not explicitly excluded archetypes
CommentComment: Comment on the sequencing assay that was not captured in other fields.
Other contributorsSimon Schumacher, HiGHmed, Germany
Christina Jaeger-Schmidt, Heidelberg University Hospital, Germany
Gideon Giacomelli, Charité Berlin, Germany
Florian Kaercher, Charité Berlin, Germany
Heather Leslie, Atomica Informatics, Australia (openEHR Editor)
Ian McNicoll, freshEHR Clinical Informatics, United Kingdom (openEHR Editor)
Silje Ljosland Bakke, Nasjonal IKT HF, Norway (openEHR Editor)
Francesca Frexia, CRS4 - Center for advanced studies, research and development in Sardinia, Italy
Cecilia Mascia, CRS4, Italy (openEHR Editor)
Paolo Uva, CRS4, Italy
Gianluigi Zanetti, CRS4, Italy
Translators
  • English: Aurelie Tomczak, Institute of Pathology, University Hospital Heidelberg, au.tomczak@yahoo.com